Listening to Patients’ Voices in Developing New Opioid Addiction Treatments
One of the pillars of the current federal initiatives to end the opioid crisis is the development of new medications to treat opioid addiction. Currently we have three approved drugs—methadone, buprenorphine, and naltrexone—in a growing number of formulations, including some […]
Listening to Patients’ Voices in Developing New Opioid Addiction Treatments Read More »